Long-term Virologic Suppression Despite Presence of Resistance-associated Mutations Among Perinatally HIV-infected Youth.

Journal: The Pediatric infectious disease journal
PMID: 26780022

Abstract

BACKGROUND: There is limited information on long-term consequences of continuing combination antiretroviral therapy (cART) consisting of <3 active drugs in treatment-experienced youth with perinatal HIV (PHIV). This study describes the clinical outcomes of PHIV youth who maintained virologic suppression (VS) for ≥1 year despite receiving cART with <3 active agents.

Authors

  • Tiffeny T Smith
    From the *Department of Pharmacy, The Johns Hopkins Hospital, Baltimore, Maryland; †Division of General Pediatrics, Department of Pediatrics, The Johns Hopkins University School of Medicine, Baltimore, Maryland; ‡University of Florida College of Pharmacy, Gainesville, Florida; §Division of Pediatric Infectious Diseases, The Johns Hopkins University, Baltimore, Maryland.
  • Alice J Hsu
  • Nancy Hutton
  • Faith Womble
  • Allison L Agwu

Keywords

External Resources

Popular Topics
Recent Journals